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Research Center, Hopital St e-Just ine and Universite de Montreal, Montreal, Canada . Role of ions in Prolactin release .
To study the role of ions in the releas e of Prolactin (PRL), several experiments were performed utilizing dispersed pituitary cells obta ined from adult, female Sprague-Dawley rats. All tests were done after a culture period of 5 days in multiwell Petri plates at 3 x lOS cells per well. Culture medium was Dulbecco's modified Eagle's medium (DMEN) supplemented with 10% horse serum, 2.5% fetal calf serum, non-essential amino-acids and antibiotics. PRL secretion was measured by specific RIA after 4 h of test incubstion in various media at 37 0 in a C0 2/air incubator. Basal PRL secretion in DMEH (154±12 ng/ml) was drastically reduced in a hypoosmolar, sodium deprived medium (48±4 ng/ml) , remained low when NaCl was replaced by isoosmolar concentrations of glucose (33±2 ng/ml), and was restored by the addition of either sodium or choline 110 mH . When DA la-11M was added to the medium with sodium, an 83% increment of PRL secretion was observed, while the neurotransmitter was completely inactive in absence of NaCl. DA 5 x 10-6M strongly inhibited PRL release in the presence of sodium but was inactive either in the absence of the ion or when the ion channel was blocked by tetrodotoxin (TTX). Baseline and DA-stimulated PRL releaae were also strongly inhibited by the sddition to the medium of either Co++ (a calcium channel blocker) or TTX. These results indicate that a normal ionic charge in the medium is essential for baseline PRL secretion, while both sodium and calcium ions are necessary for DA control of hormone release. The efficacy of Tr.M. in the treatment of C.D. in children and adoles cents has not been assessed. We trested 8 pstients (7-6/12-18-9112 yr s old) with C.D. by Tr.M. (followup 8-72 months postoperstively). Growth failure and weight gain were the first signs of C.D.; pubertsl delsy, virilizstion snd fatigsbility were varisble festures. Preoperative evslustion showed elevated urinsry free cortisol and no diurnal vsristion in plasma cortisol or ACTH vslues ; high dose dexamethasone therspy suppressed excretion of urinsry free cortisol. Two of 8 pstients lscked definite radiographic evidence of a pituitary adenoma. Transphenoidsl exploration revealed 1-4 mm adenomas in 7 of 8 patients; no definite adenoma was noted in the 8th patient in spite of CT scsn evidence of sdenoma. Postoperstive complications were limited to transient diabetes insipidus. The 7 treated patients had low cortisol snd ACTH s ec re t i on postoperatively and required replacement glucocorticoid therapy for 6-12 montha. Weight loss. growth and pubertal progression without recurrence of C.D. were noted 1n 6 patients with long term followup. Our experience indicatea that ACTH secreting microadenomas are the principal cause of C.D. in childhood and adolescence and suggesta that transphenoidal microadenectomy is the initial treatment of choice for Cushing's disease in young patients. 26 patients (6 familial) were investigated, with a followup of 4-20 yrs (x= 12.5 yrs) after anset af palyuria. Pneumoencephalography (n= 27) and/or CT scan (n= 11) were normal.
GH deficiency was present in 10/26 cases. Recovery, nat related to puberty in all cases, was abserved in 5 patients. TSH response to TRF (n= 17) was deficient (n= 3) or of the hypothalamic type (n= .). Puberty was narmal in 17 cases, and abnormal in 2 cases (respectively precocious and slowly progressing). GH deficiency was isolated i n 5 cases ar associated with ACTH +TSH (n= 1), TSH (n= 1), ACTH (n= 3) abnormalities. Hunan growth hoDrone (!Gi) is cxrnronly administrated by Lm, injections. 'lhe high purity of the present HGI preparations makes s .c, administration an attractive alternative enabling selfadministration. In this study t1Ire courses of plasna !Gi after s ,c am l.m.injections of highly purified HGI (NaroIITC<lR) are described am carpared to the diurnal plasna IIGI profile in eight nonnal children (11-14 years). Seven patients suffering fran idiopathic HGI-deficient dwarfism (age 10-19~s) received Lm. am s ,e , injection of HGI in the 1lCrn1ng (4IU/m 2) in ranclan order with an interval of one week. I.m. injections lead to a peak IIGI coocentration at 2 hoors (mean 204,range 135-475 lXl'/ml) with a return to baseline 8-10 hoors after injection.Q:lrresporrlingly IIGI concentration peaked at 4 hrs (mean 38,range 15-68 lXl'/ml)after s ,c . injection am returned to baseline a!x>ut 18 hoors after injection. In a suhseauent study on similar patients (n=7,age 10-19 years) HGI (2IUj\n2) was injected s ,c, in the evening.HG1 concentration peaked at 5 hoors (mean l7,range 7-28 lXl'/ml) am returned to baseline 14 hoors after injection.'Ibe results indicate that absorption fran an l.m. depot is far too sI"ort to give a P'IYsio1ogical diurnal profile of !Gi in plasna -even by daily aan1.n1.stration. However, daily s.c. injection wi11,if given in the evening, imitate nonnal nocturnal HGI profile. RUTH ILLIG, M. ZACHMANN and A. PRADER 
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Dept. of Pediatrics, Univenity af Zurich, Switzerland "A-type" isolated growth hormane deficiency (IGHD). In 1970, we presented the "A-type" of autosomal recessive IGHO ehereeter l:<ed by early and severe growth retordation, typical foce with vaulted forehead, a stTong metobolic and grwwth re"",OM to exogenous hGH, and a tendency to form high GH antibodies which abolish this effect.
Recent events prompt us to repart on these patients again: 1) Philipps et al (abstr.Ped.Res. 1981) carried out restriction endonuclease studies In our original family A, yielding abnormal DNA patterns of the GH genes. In other fomilies with IGHO, they found a normal pattern.
2) One of our female patients of the same family (26years, 118 em) gave birth to a healthy girl (GA 40 weeks, 2370 g,~em) . GH antibodies were found nat only in the mother (12 yean after the end of hGH 1Iy,) but also in the newborn. Five months later, no more antibodies were detectoble. 3) In anather fomily we succeeded for the first time to treat a 5 yea.-old boy with hGH over a period of 1.5 yean without the appearance of HG antibodies 10 for. This Is In contrast to his 10 yea.-old brother previously treated with a different hGH preparation who developped high titre, growth-inhibiting GH antibodies. It appean that certain hGH preparations are tolerated by th_ patients who presumobly suffer from a prenatol GH deficiency which may cause a lack of immunotolerance for hGH. Supported by the Swiss National Science Foundation Grant Na. 3.901.077 1S40
